Effectiveness of palonosetron for preventing delayed chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy in patients with gastrointestinal cancer

被引：0
|
作者：
Michiyasu Murakami
Hiroki Hashimoto
Kyohei Yamaguchi
Ikuko Yamaguchi
Shozo Senba
Takeshi Siraishi
机构：
[1] Matsuyama Red Cross Hospital,Department of Pharmacy
[2] Matsuyama Red Cross Hospital,Department of Nursing
[3] Matsuyama Red Cross Hospital,Department of Gastrointestinal Surgery
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Antiemesis; Gastrointestinal cancer; Moderately emetogenic chemotherapy; Palonosetron;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：905 / 909
页数：4
相关论文
共 50 条
  • [21] Analysis of aprepitant for prevention of chemotherapy-induced nausea and vomiting with moderately and highly emetogenic chemotherapy
    Molassiotis, Alex
    Nguyen, Allison Martin
    Rittenberg, Cynthia N.
    Makalinao, Alex
    Carides, Alexandra
    FUTURE ONCOLOGY, 2013, 9 (10) : 1443 - 1450
  • [22] Assessing the Benefit of NEPA (Fixed Combination of Netupitant/Palonosetron) for preventing Chemotherapy-induced Nausea and Vomiting (CINV) in patients at increased emetic risk receiving moderately emetogenic chemotherapy
    Karthaus, M.
    Christoph, D. C.
    Lux, M. P.
    Hofheinz, R. -D
    Jordan, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 252 - 253
  • [23] Assessing the benefit of NEPA (fixed combination of netupitant/palonosetron) for preventing chemotherapy-induced nausea and vomiting (CINV) in patients at increased emetic risk receiving moderately emetogenic chemotherapy
    Molasiotis, A.
    Aapro, M. S.
    Alonzi, A.
    Chrapava, M.
    Jordan, K.
    Roeland, E. J.
    Schwartzberg, L. S.
    Terrasanta, C.
    Olivari, S.
    Dranitsaris, G.
    ANNALS OF ONCOLOGY, 2022, 33 : 1546 - 1546
  • [24] Efficacy and safety of NEPA, a fixed-dose combination of netupitant and palonosetron, in preventing chemotherapy-induced nausea and vomiting (CINV) in patients receiving moderately emetogenic chemotherapy (MEC)
    Aapro, M.
    Rossi, G.
    Rizzi, G.
    Borroni, M. E.
    Lorusso, V.
    Karthaus, M.
    Grunberg, S.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S266 - S266
  • [25] EFFICACY OF PALONOSETRON IN PREVENTING DELAYED CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING IN PEDIATRIC PATIENTS: A META-ANALYSIS
    Yamaguchi, Atsushi
    Saito, Yoshitaka
    Takekuma, Yoh
    Sugawara, Mitsuru
    PEDIATRIC BLOOD & CANCER, 2024, 71 : S55 - S55
  • [26] PREVENTION OF CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING WITH PALONOSETRON IN PATIENTS WITH NON-HODGKIN'S LYMPHOMAS UNDERGOING REPEATED CYCLES OF MODERATELY EMETOGENIC CHEMOTHERAPY
    Choi, B.
    Borsaru, G.
    Voisin, D.
    Di Renzo, N.
    HAEMATOLOGICA, 2012, 97 : 658 - 659
  • [27] Efficacy and tolerability of aprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer after moderately emetogenic chemotherapy
    Warr, DG
    Hesketh, PJ
    Gralla, RJ
    Muss, HB
    Herrstedt, J
    Eisenberg, PD
    Raftopoulos, H
    Grunberg, SM
    Gabriel, M
    Rodgers, A
    Bohidar, N
    Klinger, G
    Hustad, CM
    Horgan, KJ
    Skobieranda, F
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) : 2822 - 2830
  • [28] Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) Associated with Moderately Emetogenic (MEC) Chemotherapy in Patients with Breast Cancer
    Webb, T.
    Hardwick, J.
    Carides, A. D.
    Street, J. C.
    CANCER RESEARCH, 2009, 69 (24) : 575S - 576S
  • [29] Palonosetron (PALO) is effective in preventing chemotherapy-induced nausea and vomiting (CINV) in patients with breast cancer
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 94 - 95
  • [30] Generic Netupitant Plus Palonosetron and Dexamethasone for Prophylaxis of Chemotherapy-Induced Nausea and Vomiting (CINV) in Cancer Patients Receiving Highly or Moderately Emetogenic Chemotherapy: A Retrospective Study
    Simhadri, Soumya
    Dayyala, Sowmya
    Musinipally, Anjani Devi
    Guram, Lavanya
    Madavi, Mamatha
    Kancha, Ramakrishna
    Puligundla, Krishna Chaitanya
    SOUTH ASIAN JOURNAL OF CANCER, 2024,
12345